Modern lifestyles are fueling chronic inflammation through poor diet, stress, inactivity, and inadequate sleep, increasing the risk of serious diseases. This article explains the causes, ... Aug 05
Psoriatic Arthritis (PsA) is a chronic, heterogeneous, systemic inflammatory musculoskeletal disease affecting roughly 20% to 30% of individuals diagnosed with cutaneous psoriasis. PsA belongs to ... Aug 04
Psoriatic Arthritis (PsA) is a chronic, heterogeneous, systemic inflammatory musculoskeletal disease affecting roughly 20% to 30% of individuals diagnosed with cutaneous psoriasis. PsA belongs to ... Aug 01
The optimization of pediatric healthcare depends on a clear understanding of the developing immune system, which undergoes continuous changes from infancy through adolescence. Recognizing how ... Jul 14
MafB may prove to be one of those pivotal switches, ensuring that the body’s cleanup crew matures properly and performs its duties faithfully.... Mar 02
If these sugar-based brakes can truly be released in humans, the future of cancer therapy may look very different. It may rely less on ... Dec 24
Newcastle Universitys researchers, for the first time, have created a single-cell atlas of prenatal human skin to understand how skin forms, and what ... Mar 18
Latest Pharma News Update... Aug 31
Dr. Milind Kulkarni, HIV specialist and Chest TB Physician explains how HIV weakens the body's immune responses, assures that AIDS is not a fatal ... Jun 14
The efficacy of Azithromycin in COVID patients have been questioned many times during the current research to find out an effective medicine for COVID. Azithromycin ... Apr 22
MASITINIB DEMONSTRATED SIGNIFICANT EFFECT ON BOTH COGNITION, MEASURED WITH ADAS-COG, AND DAILY ACTIVITY, MEASURED WITH ADCS-ADL... Dec 16
I-Mab's global collaboration with AbbVie will facilitate global development of lemzoparlimab... Dec 05
Y-mAbs Therapeutics today announced that the U.S. Food and Drug Administration (“FDA”) has approved DANYELZA (naxitamab-gqgk) for the Treatment of Neuroblastoma.... Nov 26
Basilea announces Clinical Trial Collaboration and Supply Agreement with Eli Lilly and Company for ramucirumab in the ongoing FIDES-03 study with derazantinib in gastric ... Oct 28
IncellDx to study Maraviroc, a CCR5 antagonist, in a COVID-19 phase 2 clinical trial ... Oct 20
This collaborative research, aims to elucidate the mechanism of COVID-19 aggravation based on SARS-CoV-2 infection and to create drugs that prevent the ... Oct 08
Gilead Sciences, Inc. collaborates with Jounce Therapeutics, Inc., focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers... Sep 02
A new breakthrough for treatment of Coronavirus in women... Jun 26
Research has been done by the scientists of the University of California to get a therapeutic agent... Jun 19
Vitamin D has been sidelined for its ability to better immunity here is a complied summary by a combination of researchers all across the globe ... May 18
-Advertisements-
.jpeg)
Wednesday, August 26, 2026
.jpeg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)